Avextra logo — The Essence of Cannabis-based Medicine is evidence.

Avextra

The Essence of Cannabis-based Medicine is evidence.

Founded 2019 Germany Bensheim, Germany 42 employees Series Unknown Manufacturing

General Information

Company Name Avextra
Founded Year 2019
Location Germany Bensheim, Germany +1
Employees 42
Industries Manufacturing
Funding Stage Series Unknown
Social

Get notified when Avextra moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

Recorded by Bounce Watch from public sources. Every entry below carries the date we observed it, and when we have not looked recently the page says so rather than leaving silence to imply nothing happened.

Actively Hiring Aug 09, 2026

Hiring for 1 position in the last 30 days.

About Avextra

Avextra, established in 2019, is a German-based company emerging within the Manufacturing industry. The company is driven by a vision to harness the therapeutic potential of the cannabis plant to enhance patient quality of life.

Guided by its slogan — "The Essence of Cannabis-based Medicine is evidence" — Avextra aims to develop innovative, rigorously tested, and regulator-approved cannabis-based medicines. Their mission focuses on making these pharmaceutical solutions broadly accessible, thus addressing the needs of a wide patient demographic.

Despite being a young entity, Avextra has not specified recent funding rounds or investors, indicating potential opportunities for fresh capital infusion to advance its mission and expand market presence. The blend of scientific research, regulatory compliance, and patient-centric innovation positions Avextra as a compelling consideration for investors interested in the burgeoning cannabis-based therapeutic sector.

Taxonomy: Cannabis-based Medicine, Therapeutic Potential, Quality of Life, Pharmaceutical Development, Innovative Products, Regulatory Approval, Standardized Therapeutic Options, Plant-based Medicine, Patient Population, Medical Manufacturing, Secure Solutions, Evidence-based Medicine

Services & Products

Development and manufacturing of cannabis-based medicines
Conducting clinical trials and application studies
Research and development in plant-based pharmaceuticals
Integration of end-to-end supply chain from cultivation to production

Target Customers

Patients with chronic conditions Healthcare professionals and pharmacists Palliative care specialists Medical researchers Pharmaceutical distributors

No funding data available for Avextra yet.

Get notified when Avextra raises funding

Avextra Alternatives & Competitors

Avextra vs
Veda Farms
Veda Farms United States

We are a vertically integrated Ayurvedic wellness company making plant-based alternatives to pharmac...

2 employees
E-Commerce, Health Care
Avextra vs
GESLabs
GESLabs United Kingdom

Leading Naturally

41 employees
Biotechnology, Health and Wellness
Avextra vs
RiverRock Colorado
RiverRock Colorado United States

Cultivating quality medical and recreational cannabis from Denver, Colorado.

6 employees

FAQ About Avextra

The Essence of Cannabis-based Medicine is evidence.
Avextra was founded in 2019.
Avextra is headquartered in Bensheim, Germany.
Avextra operates in the following industries: Manufacturing.
Avextra has approximately 42 employees.
Avextra offers: Development and manufacturing of cannabis-based medicines, Conducting clinical trials and application studies, Research and development in plant-based pharmaceuticals, Integration of end-to-end supply chain from cultivation to production.
Top alternatives and competitors to Avextra include Veda Farms, GESLabs, RiverRock Colorado, GrowHealthy, Infused Health. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Avextra and Veda Farms are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Avextra and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

One analytics cookie (Google Analytics). Cookie Policy